Plain language law

New Zealand law explained for everyone

Medicines Act 1981

Miscellaneous provisions

105E: Power of Director-General to specify prescription medicines for delegated prescribers

You could also call this:

"The boss of health can choose which medicines some helpers can prescribe."

Illustration for Medicines Act 1981

The Director-General can decide which prescription medicines can be given by delegated prescribers. They can choose specific medicines or groups of medicines, and different medicines can be chosen for different types of health professionals. The Director-General must talk to organisations that will be affected by their decision before making it. The Director-General must follow certain rules when making their decision, and you can find out more about these rules in Part 3 of the Legislation Act 2019. This helps ensure that the decision is made in a fair and transparent way. The Director-General's decision is a type of law called secondary legislation.

This text is automatically generated. It might be out of date or be missing some parts. Find out more about how we do this.

This page was last updated on

View the original legislation for this page at https://legislation.govt.nz/act/public/1986/0120/latest/link.aspx?id=DLM6194405.

Topics:
Health and wellbeing > Healthcare services
Previous

105D: Regulations relating to delegated prescribers, or

"Rules for People Allowed to Prescribe Medicines"

Next

105F: Incorporation by reference, or

"Using rules from other places in our medicine laws"

Part 8Miscellaneous provisions

105EPower of Director-General to specify prescription medicines for delegated prescribers

  1. The Director-General may, by notice, specify the prescription medicines, or the class or description of prescription medicines, that may be prescribed under delegated prescribing orders (and different prescription medicines, or different classes or descriptions of prescription medicines, may be specified for different classes of health professional).

  2. Before issuing a notice under subsection (1), the Director-General must consult with those organisations or bodies that appear to the Director-General to be representative of persons likely to be substantially affected by the notice.

  3. A notice under this section is secondary legislation (see Part 3 of the Legislation Act 2019 for publication requirements).

Notes
  • Section 105E: inserted, on , by section 37 of the Medicines Amendment Act 2013 (2013 No 141).
  • Section 105E(1): amended, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).
  • Section 105E(3): inserted, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).